瑞康医药：累计回购公司股份2361.3117万股

Core Viewpoint - Ruikang Pharmaceutical announced a share buyback plan, intending to repurchase 23.613117 million shares, which represents 1.57% of the company's total share capital as of September 30, 2025 [2] Group 1 - The company will conduct the share buyback through a dedicated securities account via centralized bidding [2] - The buyback is part of the company's strategy to enhance shareholder value [2]